Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127722031 | 12772203 | 1 | I | 20160913 | 20160922 | 20160922 | EXP | US-JNJFOC-20160914596 | JANSSEN | CHOW S, PATNANA S, GUPTA NK. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN A PATIENT WITH CROHN^S DISEASE ON INFLIXIMAB. J CLIN GASTROENTEROL 2016;50(8):687. | 24.00 | YR | A | F | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127722031 | 12772203 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | Y | N | 103772 | 5 | MG/KG | LYOPHILIZED POWDER |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127722031 | 12772203 | 1 | Crohn's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127722031 | 12772203 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127722031 | 12772203 | Hypertensive crisis | |
127722031 | 12772203 | Off label use | |
127722031 | 12772203 | Posterior reversible encephalopathy syndrome | |
127722031 | 12772203 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |